Literature DB >> 2438205

Contribution of the mannan O side-chains to the adjuvant action of lipopolysaccharides.

M Ohta, N Kido, T Hasegawa, H Ito, Y Fujii, Y Arakawa, T Komatsu, N Kato.   

Abstract

Klebsiella 03 lipopolysaccharide (LPS) and Escherichia coli 09 LPS were previously shown to have potent adjuvant activities in augmenting antibody response and delayed-type hypersensitivity to protein antigens. The R form LPS extracted from the O-specific polysaccharide-less mutants derived from Klebsiella 03 and E. coli 09 strains were characterized by chemical and electrophoretic analyses. The adjuvant activities of the R-LPS in augmenting antibody response and DTH to protein antigens were much weaker than those of the parental LPS. The strength of the adjuvant activities of the R-LPS was similar to that of the activities of Salmonella minnesota LPS and Ra-LPS. By contrast, polyclonal B-cell activation effects of the R-LPS were stronger than those of the parental LPS. The common feature of the parental LPS is that their O-specific polysaccharides are mannose homopolymers (mannans). From these results, it is suggested that mannose homopolymers as the O side-chains of LPS contribute to the action of LPS in enhancing strongly the T-cell dependent immune responses to protein antigens.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438205      PMCID: PMC1453288     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  14 in total

1.  Potent adjuvant action of lipopolysaccharides possessing the O-specific polysaccharide moieties consisting of mannans in antibody response against protein antigen.

Authors:  N Kido; M Ohta; H Ito; S Naito; F Nagase; I Nakashima; N Kato
Journal:  Cell Immunol       Date:  1985-03       Impact factor: 4.868

2.  Comparative studies on adjuvanticity of Klebsiella O3 lipopolysaccharide and its lipid A and polysaccharide fractions.

Authors:  N Kato; N Kido; M Ohta; S Naito
Journal:  Immunology       Date:  1985-02       Impact factor: 7.397

3.  Adjuvant action of bacterial lipopolysaccharide in induction of delayed-type hypersensitivity to protein antigens.

Authors:  M Ohta; I Nakashima; N Kato
Journal:  Cell Immunol       Date:  1982-01-01       Impact factor: 4.868

4.  Adjuvant activity of Klebsiella O3 lipopolysaccharide: comparative study using defined uniform salt forms.

Authors:  N Kato; N Kido; M Ohta; S Naito; I Nakashima
Journal:  Microbiol Immunol       Date:  1984       Impact factor: 1.955

5.  Correlation between strong adjuvanticity of Klebsiella O3 lipopolysaccharide and its ability to induce interleukin-1 secretion.

Authors:  N Kido; I Nakashima; N Kato
Journal:  Cell Immunol       Date:  1984-05       Impact factor: 4.868

6.  Adjuvant action of bacterial lipopolysaccharide in induction of delayed-type hypersensitivity to protein antigens. II. Relationships of intensity of the action to that of other immunological activities.

Authors:  M Ohta; I Nakashima; N Kato
Journal:  Immunobiology       Date:  1982-12       Impact factor: 3.144

7.  B cell activation and adjuvant activities of chemically synthesized analogues of the nonreducing sugar moiety of lipid A.

Authors:  Y Kumazawa; M Matsuura; J Y Homma; Y Nakatsuru; M Kiso; A Hasegawa
Journal:  Eur J Immunol       Date:  1985-02       Impact factor: 5.532

8.  Immunopharmacological activities of a synthetic counterpart of a biosynthetic lipid A precursor molecule and of its analogs.

Authors:  H Takada; S Kotani; M Tsujimoto; T Ogawa; I Takahashi; K Harada; C Katsukawa; S Tanaka; T Shiba; S Kusumoto
Journal:  Infect Immun       Date:  1985-04       Impact factor: 3.441

9.  Inhibition by succinyl concanavalin A of strong adjuvant activity of lipopolysaccharides which possess mannans as the O-specific polysaccharide chains.

Authors:  N Kido; M Ohta; N Kato
Journal:  Cell Immunol       Date:  1985-05       Impact factor: 4.868

10.  Cellular requirements for lipopolysaccharide adjuvanticity. A role for both T lymphocytes and macrophages for in vitro responses to particulate antigens.

Authors:  J R McGhee; J J Farrar; S M Michalek; S E Mergenhagen; D L Rosenstreich
Journal:  J Exp Med       Date:  1979-04-01       Impact factor: 14.307

View more
  4 in total

1.  Marked reduction of mouse peritoneal CD5+ B cells by intraperitoneal administration of lipopolysaccharide.

Authors:  N Paeng; N Kido; Y Kato; T Sugiyama; N Koide; M Naruse; G Z Jiang; T Lwin; T Yoshida; T Yokochi
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

2.  Retention of bacterial lipopolysaccharide at the site of subcutaneous injection.

Authors:  T Yokochi; Y Inoue; J Yokoo; Y Kimura; N Kato
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

3.  Augmented immunological activities of recombinant lipopolysaccharide possessing the mannose homopolymer as the O-specific polysaccharide.

Authors:  N Paeng; N Kido; G Schmidt; T Sugiyama; Y Kato; N Koide; T Yokochi
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

4.  Binding studies of a monoclonal antibody specific for 3-deoxy-D-manno-octulosonic acid with a panel of Klebsiella pneumoniae lipopolysaccharides representing all of the O serotypes.

Authors:  N M van der Meer; B J Appelmelk; A M Verweij-van Vught; W Nimmich; P Kosma; L G Thijs; J de Graaff; D M MacLaren
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.